Exquisite CorporationAugust 1, 2024

FDA 483 - Exquisite Corporation - August 01, 2024

Record Details

This 483 record concerns Exquisite Corporation, with an inspection on August 1, 2024, issued by the Division of Pharmaceutical Quality Operations IV, covering drugs.

Company: Exquisite Corporation
Inspection Date: August 1, 2024
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Sara H. Gabel

Open in Dashboard

ID · 7adbc9a0-7cf9-4056-88b8-7d277f5fd230